This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Liver/ Biliary Tract/ Pancreatic Diseases  • Hematology/ Hematologic Malignancies  • Coagulation Disorders  • Liver Transplantation  • Transplantation, Other  • Alert me on articles by topic

Steven D. Colquhoun, MD

Arch Surg. 2007;142(11):1058.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Marubashi et al have presented their data regarding the effect of allograft size on thrombocytopenia after living donor liver transplant. The authors note that posttransplant thrombocytopenia contributes to bleeding, infection, and "a higher incidence of morbidity" and, for those with recurrent hepatitis C virus infection, it can be a contraindication to interferon therapy. The results of the study are based on the posttransplant portal venous pressure (PVP) measurements from a subset of patients. A separate smaller group underwent splenectomy, but their selection for splenectomy apparently was not based on PVP measurements. The authors found that recipients of smaller grafts tended to have higher PVPs after transplant and a persistence of relative thrombocytopenia. Among those undergoing splenectomy, platelet counts were consistently higher, regardless of the graft volume. The authors conclude that splenectomy at the time of living donor liver transplant is indicated in those recipients with relatively . . . [Full Text of this Article]

AUTHOR INFORMATION

RELATED ARTICLE

Impact of Graft Size on Postoperative Thrombocytopenia in Living Donor Liver Transplant
Shigeru Marubashi, Keizo Dono, Atsushi Miyamoto, Yutaka Takeda, Hiroaki Nagano, Koji Umeshita, and Morito Monden
Arch Surg. 2007;142(11):1054-1058.
ABSTRACT | FULL TEXT